Further Study Needed into Rituxan Use and Its Outcomes in Lupus Patients, Review Suggests
Factors that might be predictive of different responses and outcomes in systemic lupus erythematosus (SLE) patients who are treated with Rituxan (rituximab) still need to be validated in future studies to enable better and more personalized treatment, a literature review suggests. The study, “Predictive and prognostic…